Christopher David Ozeroff, S.V.P, General Counsel at ARCA biopharma, Inc. (ABIO), sold 366 shares at $3.52 ($1K) on 2016-04-05, disclosed to the SEC on 2016-04-06.
Scheduled sale ($1k) by S.V.P, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABIO | SELL | 2017-03-01 | $1K | — | Filing → |
| ABIO | SELL | 2016-09-21 | $3K | — | Filing → |
| ABIO | SELL | 2016-03-02 | $2K | — | Filing → |